glp-1 drugs impact on energy levels How Weight-Loss Affect Appetite, Mood, and Behavior PDB-101: Molecule of the Month:
Description
doi: 10.1016/j.brainres.2012.07.029 168 ParthsarathyVHolscherC

Drugs belonging to this class include liraglutide, semaglutide, and dulaglutide, among others

Med Res Rev

In 2020, it was estimated that nearly 462 million people worldwide suffer from the disorder

The weight loss ranges of the two treatment groups were -6.9 kg (-7%) and -9.7 kg (-9.6%), respectively

Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)
